Skip to main content
. Author manuscript; available in PMC: 2018 May 7.
Published in final edited form as: Pediatr Blood Cancer. 2017 Jul 14;64(12):10.1002/pbc.26714. doi: 10.1002/pbc.26714

TABLE 4.

Survival outcome for patients with inherited bone marrow failure syndrome and AML

Inherited bone
marrow failure
syndrome		 Total number of
patients reported
with progression to
AML with data on
survival outcomes		 Total number of
patients with
progression to AML
who have died (% of
total patients with
AML)
Fanconi anemia 19 10 (52.6)
Shwachman–Diamond syndrome 10 5 (50)
GATA2 deficiency 25 17 (68)
Dyskeratosis congenita 0 0
Diamond–Blackfan anemia 3 3 (100)
Familial platelet disorder 17 14 (82.4)
Congenital amegakaryocytic thrombocytopenia 2 2 (100)
Severe congenital neutropenia 22 15 (68.2)